Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus [4]

Bone Marrow Transplantation

Volumn 36, Issue 1, 2005, Pages 87-88

  Schmook, T ^a   Kraft, J ^c   Benninghoff, B ^b   Nindl, I ^a   Roewert, J ^a   Ulrich, C ^a   Stockfleth, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b 3M Deutschland GmbH   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DOUGLAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; PREDNISOLONE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LEUKEMIA; BACTERIAL INFECTION; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; DIFFERENTIAL DIAGNOSIS; ECZEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LETTER; MYCOSIS; PRIORITY JOURNAL; PRURITUS; SEBORRHEIC DERMATITIS; SKIN ATROPHY; SKIN BIOPSY; SKIN DISEASE;

ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MIDDLE AGED; SKIN DISEASES; TACROLIMUS; TREATMENT OUTCOME;

EID: 21744441346     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704998     Document Type: Letter

References (6)

1. Ferrara JL, Cooke KR, Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003; 78: 181-187.
2. Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol 2004; 125: 435-454.
3. Choi CJ, Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch Dermataol 2004; 137: 1202-1206.
4. Elad S, Or R, Resnick I, Shapira MY. Topical tacrolimus - a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transplant Int 2003; 16: 665-670.
5. Gupta AK, Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003; 17: 493-503.
6. Alomar A, Berth-Jones J, Bos JD et al. European Working Group on Atopic Dermatitis. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 2004; 151 (Suppl. 70): 3-27.